Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Abiraterone products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 4, 2026.
A hormone therapy used to treat advanced prostate cancer.
Products affected
1 / 6
In shortage since
Jun 8, 2026
Est. full return
Sep 4, 2026
Reports on file
16
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
SANDOZ ABIRATERONE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02521644 · since Jun 8, 2026, est. end Sep 4, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ ABIRATERONE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02521644 · ended Oct 31, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ABIRATERONE
250MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02486393 · ended May 12, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
MAR-ABIRATERONE
250MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02503980 · ended May 1, 2025 · Delay in shipping of the drug.
Resolved
SANDOZ ABIRATERONE
500MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02521644 · ended Feb 17, 2025 · Demand increase for the drug.
Resolved
APO-ABIRATERONE FILM COATED TABLETS
250MG · TABLET · APOTEX INC
DIN 02491397 · ended Feb 29, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-ABIRATERONE FILM COATED TABLETS
500MG · TABLET · APOTEX INC
DIN 02491400 · ended Nov 16, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-ABIRATERONE FILM COATED TABLETS
250MG · TABLET · APOTEX INC
DIN 02491397 · ended Nov 16, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-ABIRATERONE FILM COATED TABLETS
500MG · TABLET · APOTEX INC
DIN 02491400 · ended Aug 1, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-ABIRATERONE FILM COATED TABLETS
250MG · TABLET · APOTEX INC
DIN 02491397 · ended Jul 12, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-ABIRATERONE FILM COATED TABLETS
500MG · TABLET · APOTEX INC
DIN 02491400 · ended Jul 12, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-ABIRATERONE FILM COATED TABLETS
250MG · TABLET · APOTEX INC
DIN 02491397 · ended Jan 9, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 16 reports. All reports are on file with Health Canada.
What's happening
Abiraterone is currently affected by an active shortage report filed with Health Canada by SANDOZ CANADA INCORPORATED.
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Abiraterone is classified under “HORMONE ANTAGONISTS AND RELATED AGENTS” (ATC L02BX).
Recent changes
No changes recorded yet.
Common questions
What is Abiraterone used for?
A hormone therapy used to treat advanced prostate cancer.
When will Abiraterone be back in stock in Canada?
The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Abiraterone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.